Searchable abstracts of presentations at key conferences in endocrinology

ea0034p172 | Neoplasia, cancer and late effects | SFEBES2014

Late presentation predicts endocrine dysfunction in patients with Langerhans cell histiocytosis: a retrospective analysis of the West of Scotland LCH service 1998–2012

Coyte Aishah , Murphy Dermot , Ronghe Milind Dattatraya , Sastry Jairam , Ahmed Faisal , Shaikh Mohamad Guftar

Introduction: Langerhans cell histiocytosis (LCH) is a rare condition primarily affecting children. It is characterised by clonal proliferation of Langerhans cells. Disease severity is dependent on the type and number of organs involved in addition to focality. Disease aetiology remains unclear. We aimed to record the incidence and characteristics of West of Scotland LCH patients with a focus on predictive factors for endocrine dysfunction.Method: Consec...

ea0028p149 | Neoplasia, cancer and late effects | SFEBES2012

Use of Vandetenib in metastatic medullary carcinoma of thyroid in a paediatric patient with Multiple Endocrine Neoplasia (MEN)2B

Narayanan Vidya , Bradshaw Nicola , Davidson Rosemarie , Welbury Richard , Macgregor Fiona , Ronghe Milind , Reed Nick , Shaikh Mohammed

Vandetenib has been used as novel treatment of locally invasive medullary carcinoma of thyroid. We report the use of Vandetenib in a paediatric patient with inoperable medullary carcinoma of thyroid gland. Our patient presented to the dental surgeons at age 12 years with tongue and lip swellings. Biopsy demonstrated mucosal neuromas suggestive of MEN2B. He was clinically euthyroid but had a firm goitre. Ultrasound showed a large heterogenous thyroid mass encasing the common ca...